154 related articles for article (PubMed ID: 24435454)
21. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
22. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
[No Abstract] [Full Text] [Related]
23. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
24. Human menopausal gonadotropin during in vitro maturation of human oocytes retrieved from small follicles enhances in vitro fertilization and cleavage rates.
Zhang X; Zerafa A; Wong J; Armstrong DT; Khamsi F
Fertil Steril; 1993 Apr; 59(4):850-3. PubMed ID: 8458507
[TBL] [Abstract][Full Text] [Related]
25. Ovarian response to gonadotropin stimulation in repeated IVF cycles after unilateral salpingectomy.
Tal J; Paltieli Y; Korobotchka R; Ziskind G; Eibschitz I; Ohel G
J Assist Reprod Genet; 2002 Oct; 19(10):451-5. PubMed ID: 12416648
[TBL] [Abstract][Full Text] [Related]
26. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
27. Results of in vitro fertilization cycles in women aged 43-45 years.
Orvieto R; Bar-Hava I; Yoeli R; Ashkenazi J; Rabinerson D; Bar J; Fisch B
Gynecol Endocrinol; 2004 Feb; 18(2):75-8. PubMed ID: 15195498
[TBL] [Abstract][Full Text] [Related]
28. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
Zhang Z; Zhang XH; He TY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
[TBL] [Abstract][Full Text] [Related]
29. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
[TBL] [Abstract][Full Text] [Related]
30. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].
Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186
[TBL] [Abstract][Full Text] [Related]
31. [Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer].
Chen SL; Xia R; Chen X; Luo YQ; Wang LL; Wu YQ; Shi XY; Zheng HY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):572-7. PubMed ID: 21515446
[TBL] [Abstract][Full Text] [Related]
32. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.
Ho VNA; Braam SC; Pham TD; Mol BW; Vuong LN
Hum Reprod; 2019 Jun; 34(6):1055-1064. PubMed ID: 31111879
[TBL] [Abstract][Full Text] [Related]
34. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
Beguería R; García D; Vassena R; Rodríguez A
Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
[TBL] [Abstract][Full Text] [Related]
35. Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.
Li A; Zhang J; Kuang Y; Yu C
Front Endocrinol (Lausanne); 2020; 11():427. PubMed ID: 32765424
[No Abstract] [Full Text] [Related]
36. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
[TBL] [Abstract][Full Text] [Related]
37. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
Quaas AM; Missmer SA; Ginsburg ES
Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
[TBL] [Abstract][Full Text] [Related]
39. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
Fabris AM; Cruz M; Legidos V; Iglesias C; Muñoz M; García-Velasco JA
Reprod Sci; 2017 Aug; 24(8):1221-1225. PubMed ID: 28715965
[TBL] [Abstract][Full Text] [Related]
40. Effect of low-dose aspirin therapy on implantation rate in women undergoing in-vitro fertilization cycles.
Moini A; Zafarani F; Haddadian S; Ahmadi J; Honar H; Riazi K
Saudi Med J; 2007 May; 28(5):732-6. PubMed ID: 17457441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
